S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 21.35 SEK -1.16%
Market Cap: 1B SEK

Wall Street
Price Targets

SYNACT Price Targets Summary
SynAct Pharma AB

Wall Street analysts forecast SYNACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYNACT is 21.42 SEK with a low forecast of 21.21 SEK and a high forecast of 22.05 SEK.

Lowest
Price Target
21.21 SEK
1% Downside
Average
Price Target
21.42 SEK
0% Upside
Highest
Price Target
22.05 SEK
3% Upside
SynAct Pharma AB Competitors:
Price Targets
XGN
Exagen Inc
13% Upside
BONEX
Bonesupport Holding AB
46% Upside
IMTX
Immatics NV
145% Upside
4974
Takara Bio Inc
56% Upside
FYB
Formycon AG
89% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
7% Downside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
21% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
SynAct Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SYNACT's stock price target?
Price Target
21.42 SEK

According to Wall Street analysts, the average 1-year price target for SYNACT is 21.42 SEK with a low forecast of 21.21 SEK and a high forecast of 22.05 SEK.

Back to Top